Indication
Dupuytren's Contracture
6 clinical trials
6 products
2 drugs
Clinical trial
Nodular Shrinking in Stage 0 Dupuytren Disease: an Evidence-based Approach for Early Stage Treatment to Prevent Progression to Advanced Finger ContracturesStatus: Recruiting, Estimated PCD: 2026-03-01
Product
Vitamin E-cremeClinical trial
DupuytrEn Treatment EffeCtiveness Trial (DETECT): Needle Fasciotomy, Surgery or Collagenase Injection for Dupuytren's ContractureStatus: Active (not recruiting), Estimated PCD: 2026-05-31
Clinical trial
Percutaneous Needle Fasciotomy (PNF) +/- Corticosteroid Injection for Dupuytren's Contracture (DC) Affecting Metacarpophalangeal Joints (MCP) . A Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2025-12-01
Product
CorticosteroidClinical trial
A Multi-Center, Randomized Controlled Trial Comparing The Clinical Effectiveness and Cost-Effectiveness of Collagenase Injection (Xiaflex) and Palmar Fasciectomy in the Management of Dupuytren's DiseaseStatus: Completed, Estimated PCD: 2021-12-17
Product
CollagenaseClinical trial
Clinical Effectiveness of Splinting After Collagenase Clostridium Histolyticum Injection for Dupuytren ContractureStatus: Completed, Estimated PCD: 2023-12-01
Product
XiaflexClinical trial
A Multi-centre, Double Blind, Randomised, Placebo-controlled, Parallel Group, Phase II Trial to Determine the Efficacy of Intra-nodular Injection of Anti-TNF to Control Disease Progression in Early Dupuytren's Disease, With a Dose Response.Status: Completed, Estimated PCD: 2020-11-01
Drug
AdalimumabDrug
Varlilumab